Evidence map›Paper›PMID 29474672›Full record

ArticleJournal of neuropathology and experimental neurology2018

Leptomeninges-Derived Induced Pluripotent Stem Cells and Directly Converted Neurons From Autopsy Cases With Varying Neuropathologic Backgrounds.

Shannon E Rose, Harald Frankowski, Allison Knupp, Bonnie J Berry, Refugio Martinez, Stephanie Q Dinh, Lauren T Bruner, Sherry L Willis, Paul K Crane, Eric B Larson and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. The Alzheimer's disease risk gene SORL1 is a regulator of excitatory neuronal function.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Loss of function of the chromatin remodeling geneProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Use ofFrontiers in cellular and infection microbiology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Shannon E RoseDepartment of Pathology, University of Washington, Seattle, Washington.
Harald FrankowskiDepartment of Pathology, University of Washington, Seattle, Washington.
Allison KnuppDepartment of Pathology, University of Washington, Seattle, Washington.
Bonnie J BerryDepartment of Pathology, University of Washington, Seattle, Washington.
Refugio MartinezDepartment of Pathology, University of Washington, Seattle, Washington.
Stephanie Q DinhDepartment of Pathology, University of Washington, Seattle, Washington.
Lauren T BrunerDepartment of Pathology, University of Washington, Seattle, Washington.
Sherry L WillisDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington.
Paul K CraneDepartment of Medicine, University of Washington, Seattle, Washington.
Eric B LarsonKaiser Permanente Washington Health Research Institute, University of Washington, Seattle, Washington.
Thomas GrabowskiDepartment of Radiology and Neurology, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington.
Martin DarvasDepartment of Pathology, University of Washington, Seattle, Washington.
C Dirk KeeneDepartment of Pathology, University of Washington, Seattle, Washington.
Jessica E YoungDepartment of Pathology, University of Washington, Seattle, Washington.
University of Washington · USKaiser Permanente Washington Health Research Institute · US

Funding

THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI JAYADEY, SUMAN · 1985 to 2019
$57.2M
Udall Center Director's meeting poster awardP50NS062684 · NINDS · UNIVERSITY OF WASHINGTON · PI MONTINE, THOMAS J · 2009 to 2020
$18.3M
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7M
NIA NIH HHS P50 AG005136NIA NIH HHS T32 AG052354NINDS NIH HHS P50 NS062684
6 · The paper itself

Abstract

Patient-specific stem cell technology from skin and other biopsy sources has transformed in vitro models of neurodegenerative disease, permitting interrogation of the effects of complex human genetics on neurotoxicity. However, the neuropathologic changes that underlie cognitive and behavioral phenotypes can only be determined at autopsy. To better correlate the biology of derived neurons with age-related and neurodegenerative changes, we generated leptomeningeal cell lines from well-characterized research subjects that have undergone comprehensive postmortem neuropathologic examinations. In a series of proof of principle experiments, we reprogrammed autopsy leptomeningeal cell lines to human-induced pluripotent stem cells (hiPSCs) and differentiated these into neurons. We show that leptomeningeal-derived hiPSC lines can be generated from fresh and frozen leptomeninges, are pluripotent, and retain the karyotype of the starting cell population. Additionally, neurons differentiated from these hiPSCs are functional and produce measurable Alzheimer disease-relevant analytes (Aβ and Tau). Finally, we used direct conversion protocols to transdifferentiate leptomeningeal cells to neurons. These resources allow the generation of in vitro models to test mechanistic hypotheses as well as diagnostic and therapeutic strategies in association with neuropathology, clinical and cognitive data, and biomarker studies, aiding in the study of late-onset Alzheimer disease and other age-related neurodegenerative diseases.

Indexed as

AutopsyAlzheimer DiseaseAmyloid beta-PeptidesCell DifferentiationCell LineEmbryoid BodiesHumansInduced Pluripotent Stem CellsKaryotypeMeningesNervous System DiseasesNeuronsPolymerase Chain Reactiontau ProteinsAmyloid beta-Peptidestau Proteins

Identifiers

PMID29474672
PMCPMC6018913
OpenAlexW2809369923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.